back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2025-05-21 19:10 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
-622,096 vol |
500,000 | |
| Filed 2025-05-21 19:09 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
-666,666 vol |
1,122,096 | |
| Filed 2025-05-21 19:06 Tx date 2025-05-09 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
58 - Expiration of rights
|
-333,333 vol |
1,788,762 | |
| Filed 2025-05-06 08:41 Tx date 2025-05-05 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$1,000,000
+10,000,000 vol $0.10 each |
27,289,711 | |
| Filed 2025-01-18 07:16 Tx date 2025-01-17 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
11 - Acquisition or disposition carried out privately
|
$100,000
+1,000,000 vol $0.10 each |
17,289,711 | |
| Filed 2024-07-18 07:16 Tx date 2024-07-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+333,333 vol |
2,122,095 | |
| Filed 2024-04-22 08:43 Tx date 2024-04-17 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$-260,000
-2,000,000 vol $0.13 each |
16,289,711 | |
| Filed 2023-09-13 10:30 Tx date 2021-12-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
55 - Expiration of warrants
|
-12,571,428 vol |
0 | |
| Filed 2023-06-28 22:26 Tx date 2023-06-23 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+666,666 vol |
1,788,762 | |
| Filed 2021-07-26 10:03 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
56 - Grant of rights
|
+1,122,096 vol |
1,122,096 | |
| Filed 2021-07-26 10:01 Tx date 2010-09-15 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Restricted Share Units
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-07-26 10:00 Tx date 2021-07-20 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
38 - Redemption, retraction, cancellation, repurchase
|
-1,290,000 vol |
0 | |
| Filed 2021-04-26 09:06 Tx date 2021-04-22 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$180,000
+1,000,000 vol $0.18 each |
18,289,711 | |
| Filed 2021-04-26 08:28 Tx date 2021-04-22 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
54 - Exercise of warrants
|
$-180,000
-1,000,000 vol $0.18 each |
12,571,428 | |
| Filed 2020-09-29 12:30 Tx date 2020-08-19 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$44,800
+280,000 vol $0.16 each |
1,290,000 | |
| Filed 2020-06-28 19:31 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
13,300,000 | |
| Filed 2018-11-15 15:11 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
||
| Filed 2017-07-20 16:05 Tx date 2017-07-14 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Warrants
11 - Acquisition or disposition carried out privately
|
$2,250,000
+12,500,000 vol $0.18 each |
||
| Filed 2020-03-07 16:13 Tx date 2020-01-12 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
52 - Expiration of options
|
$-35,000
-100,000 vol $0.35 each |
610,000 | |
| Filed 2020-03-07 15:56 Tx date 2020-02-28 |
$KNE
Kane Biotech Inc. |
Renaud, Philip
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$72,000
+400,000 vol $0.18 each |
1,110,000 |